Stockscreener 앱 받기
11.36
3.09%
0.34
전일 마감가:
$11.02
열려 있는:
$11.12
하루 거래량:
1.64M
Relative Volume:
0.61
시가총액:
$1.72B
수익:
$5.75B
순이익/손실:
$77.00M
주가수익비율:
23.18
EPS:
0.49
순현금흐름:
$-675.00M
1주 성능:
+5.09%
1개월 성능:
-22.19%
6개월 성능:
-42.51%
1년 성능:
-56.92%
1일 변동 폭
$11.05
$11.45
1주일 범위
$10.45
$11.70
52주 변동 폭
$9.33
$29.21
Chemours Company Stock (CC) Company Profile
명칭
Chemours Company
전화
302 773 1000
주소
1007 MARKET STREET, WILMINGTON, DE
CC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CC
Chemours Company
|
11.36 | 1.72B | 5.75B | 77.00M | -675.00M | 0.49 |
|
LIN
Linde plc Ordinary Share
|
452.12 | 210.93B | 33.01B | 6.57B | 4.93B | 13.61 |
|
SHW
Sherwin Williams Co
|
333.38 | 85.77B | 23.10B | 2.68B | 2.08B | 10.55 |
|
ECL
Ecolab Inc
|
238.73 | 67.68B | 15.74B | 2.11B | 1.82B | 7.38 |
|
APD
Air Products Chemicals Inc
|
262.90 | 60.64B | 12.03B | 3.84B | -3.64B | 17.22 |
|
DD
Dupont De Nemours Inc
|
60.14 | 25.52B | 12.39B | 703.00M | 1.42B | 1.67 |
Chemours Company Stock (CC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-27 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-01-28 | 개시 | Truist | Buy |
| 2024-07-09 | 업그레이드 | UBS | Neutral → Buy |
| 2024-06-07 | 개시 | Mizuho | Neutral |
| 2024-04-09 | 업그레이드 | BMO Capital Markets | Underperform → Outperform |
| 2024-03-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-29 | 다운그레이드 | BMO Capital Markets | Outperform → Underperform |
| 2023-12-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-24 | 업그레이드 | UBS | Neutral → Buy |
| 2023-01-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | 개시 | Credit Suisse | Underperform |
| 2022-10-13 | 개시 | Goldman | Neutral |
| 2022-10-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-06-10 | 개시 | Wolfe Research | Outperform |
| 2021-06-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-05-20 | 개시 | BofA Securities | Buy |
| 2021-05-06 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-08 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-11-30 | 개시 | Alembic Global Advisors | Overweight |
| 2020-03-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-02-14 | 업그레이드 | CFRA | Buy → Strong Buy |
| 2019-11-06 | 업그레이드 | CFRA | Hold → Buy |
| 2019-08-20 | 업그레이드 | Susquehanna | Neutral → Positive |
| 2019-08-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | 다운그레이드 | Argus | Buy → Hold |
| 2019-08-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-07-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-05-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-04-15 | 업그레이드 | SunTrust | Hold → Buy |
| 2019-02-19 | 다운그레이드 | Susquehanna | Positive → Neutral |
| 2019-01-08 | 개시 | HSBC Securities | Buy |
| 2019-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-11-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2018-01-30 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-12-06 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-08-07 | 업그레이드 | UBS | Sell → Neutral |
모두보기
Chemours Company 주식(CC)의 최신 뉴스
Lobbying Update: $530,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Nasdaq
Chemours Supports STEM Education With "STEAM Machine" - CSRwire
A Wilmington Republican is once again pushing for Chemours to pay for filtration of forever chemicals - WFAE
Dutch prosecutors raid Chemours plant in PFAS criminal case over toxic pollution - ehn.org
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call | CC Stock News - GuruFocus
Chemours Announces Dates for First Quarter 2025 Earnings Release and Webcast Conference Call - The Joplin Globe
Chemours Q1 2025 Earnings Coming May 6: Key Financial Results and Analyst Call Details - Stock Titan
Lobbying Update: $130,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Nasdaq
Chemours price target lowered to $15 from $19 at Mizuho - Yahoo Finance
Groups move for disclosure of Chemours’ sealed documents - Coastal Review
Chemours (CC) Price Target Lowered by Mizuho Analyst Amid Sector Adjustments | CC Stock News - GuruFocus
Police raid Chemours plant in Dordrecht in criminal probe over toxic PFAS emissions - NL Times
Environmentalist groups file motion to disclose Chemours’ documents - Port City Daily
Learn to Evaluate (CC) using the Charts - news.stocktradersdaily.com
Chemours price target lowered to $22 from $27 at Truist - TipRanks
What 6 Analyst Ratings Have To Say About Chemours - Benzinga
At US$11.28, Is The Chemours Company (NYSE:CC) Worth Looking At Closely? - Yahoo Finance
ATTENTION The Chemours Company Investors: You May Have Been Affected by FraudContact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire
PFAS found in dust of homes in Bladen and Cumberland counties near Chemours plant - bladenonline.com
Nation Ford Chemical Recognized by The Chemours Company in its 2024 Responsible Supplier Awards in the Star Supplier Award Category - Yahoo Finance
Chemours Announces the Winners of Its Fifth Annual Responsible Supplier Awards - CSRwire
RBC Capital cuts Chemours stock target to $17, keeps Outperform By Investing.com - Investing.com South Africa
Chemours to fund costly cleanup of PFAS-contaminated gardens in Dordrecht - ehn.org
RBC Capital cuts Chemours stock target to $17, keeps Outperform - Investing.com
Chemours price target lowered to $17 from $25 at RBC Capital - TipRanks
Fluorochemicals Market 2025: Challenges, Opportunities, - openPR.com
RBC Cuts Price Target on Chemours to $17 From $25, Keeps Outperform Rating - marketscreener.com
Chemours upgraded at Mizuho as headwinds begin to shift - MSN
Chemours stock plunges to 52-week low at $9.64 amid market challenges By Investing.com - Investing.com South Africa
Chemours stock plunges to 52-week low at $9.64 amid market challenges - Investing.com India
Dutch MPs rally for health over profit in Chemours PFAS dispute - ehn.org
The Chemours Company Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsCC - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations - ACCESS Newswire
Chemours and DuPont's knowledge of PFAS risks leads to UN intervention - ehn.org
Chemours Co. Hit With Insider Derivative Suit In Del. - Law360
Creating a Domestic Supply Chain of Critical Minerals for the United States - CSRwire
Chemours and Energy Fuels Forming Strategic Alliance for Domestic Supply Chain of Critical Minerals - Coatings World
Chemours, Energy Fuels partner to boost critical minerals supply chain - Supply Chain Dive
Institutional investors may adopt severe steps after The Chemours Company's (NYSE:CC) latest 22% drop adds to a year losses - simplywall.st
Chemours, water utilities’ joint suit to overturn federal PFAS drinking water standards faces uncertain future - Port City Daily
No NC limit on 1,4-dioxane means water customers bear costs - North Carolina Health News
‘Our rights don’t begin when it’s convenient for a shareholder’: Protesters demand action on toxic water crisis - CityView NC
'Clean up the mess': Fayetteville rally calls for more action to remove PFAS from water - The Fayetteville Observer
Expanded well testing for PFAS: what you need to know - Border Belt Independent -
An Investigation Has Commenced on Behalf of The Chemours Company Shareholders. Contact Levi & Korsinsky to Discuss your CC Losses - ACCESS Newswire
Poisoned land: Cumberland residents say PFAS was overlooked in property revaluations - The Fayetteville Observer
Titanium Dioxide Market Top Companies Analysis, In-Depth - openPR.com
Toxic dust? PFAS found in homes near NC plant - WRAL.com
Chemours attempts to block internal docs in lawsuit with local utility authorities, governments - Port City Daily
Renowned Litigation Firm Labaton Keller Sucharow LLP is Investigating The Chemours Company for Securities Violations and Encourages Investors to Contact the Firm - ACCESS Newswire
Chemours stock hits 52-week low at $13.07 amid market challenges - Investing.com
Chemours Company (CC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.69%
0.02%
자본화:
|
볼륨(24시간):